PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling

Abstract

PKC-δ is an important molecule for B-cell proliferation and tolerance. B cells have long been recognized to play a part in osteoimmunology and pathological bone loss. However, the role of B cells with PKC-δ deficiency in bone homeostasis and the underlying mechanisms are unknown. We generated mice with PKC-δ deletion selectively in B cells by crossing PKC-δ-loxP mice with CD19-Cre mice. We studied their bone phenotype using micro-CT and histology. Next, immune organs were obtained and analyzed. Western blotting was used to determine the RANKL/OPG ratio in vitro in B-cell cultures, ELISA assay and immunohistochemistry were used to analyze in vivo RANKL/OPG balance in serum and bone sections respectively. Finally, we utilized osteoclastogenesis to study osteoclast function via hydroxyapatite resorption assay, and isolated primary calvaria osteoblasts to investigate osteoblast proliferation and differentiation. We also investigated osteoclast and osteoblast biology in co-culture with B-cell supernatants. We found that mice with PKC-δ deficiency in B cells displayed an osteopenia phenotype in the trabecular and cortical compartment of long bones. In addition, PKC-δ deletion resulted in changes of trabecular bone structure in association with activation of osteoclast bone resorption and decrease in osteoblast parameters. As expected, inactivation of PKC-δ in B cells resulted in changes in spleen B-cell number, function, and distribution. Consistently, the RANKL/OPG ratio was elevated remarkably in B-cell culture, in the serum and in bone specimens after loss of PKC-δ in B cells. Finally, in vitro analysis revealed that PKC-δ ablation suppressed osteoclast differentiation and function but co-culture with B-cell supernatant reversed the suppression effect, as well as impaired osteoblast proliferation and function, indicative of osteoclast–osteoblast uncoupling. In conclusion, PKC-δ plays an important role in the interplay between B cells in the immune system and bone cells in the pathogenesis of bone lytic diseases.

Wheel-Running Exercise Protects Ovariectomized Mice from Bone Loss via IFN-γ-Mediated Suppression of the NF-κB and MAPK Pathways

“…The serum levels of amino-terminal propeptide of type 1 procollagen (P1NP), type 1 collagen C-terminal telopeptide (CTX-1), and interferon-gamma (IFN- γ ) were measured by ELISA kits (Elabscience, Wuhan, China) according to the manufacturer's instructions. The intra-assay and interassay coefficients of variation were below 6.5% and 7.0% for P1NP [ 31 ], 5.5% and 6.0% for CTX-1 [ 32 ], and 6.5% and 7.0% for IFN- γ [ 33 ]. Quantification was measured using a microplate reader (Thermo Fisher Scientific, Waltham, USA) at 450 nm.…”

The Rising Era of “Immunoporosis”: Role of Immune System in the Pathophysiology of Osteoporosis

“…Emerging evidence highlights the potential of B cells in osteo-immunological regulation that is further supported by the physiological and anatomical coexistence of B cells and bone cells in BM. 121 Recently, several findings suggested that B cells are the active modulator of the RANKL/OPG axis and the production of RANKL by B cells further augmented bone loss in ovariectomy induced bone loss. 122 Interestingly, a report suggested that along with enhancing the OCs differentiation RANKL also increases B cell number that further acts as an OCs supporter cell.…”

Protein kinase Cδ is essential for the IgG response against T cell-independent type 2 antigens and commensal bacteria

“…Prkcd fl/fl mice on the B6 background were developed by Drs. Niino, Shioda and Sakimura (Li et al, 2020) and purchased from the RIKEN BioResource Center (RBRC06462). Mice were immunized i.p.…”